Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Volatile Organic Compounds in Breath and Headspace Analysis - Diagnostic and Monitoring Markers for Diseases

NCT03228095 is registered in ClinicalTrials.gov with University of Latvia as lead sponsor.

NCT NCT03228095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Volatile Organic Compounds in Breath and Headspace Analysis - Diagnostic and Monitoring Markers for Diseases
Lead sponsor
University of Latvia
Phase
Observational
Overall status
Unknown status
Start date
July 24, 2017
Completion date
December 31, 2025
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, colorectal adenoma, colorectal cancer, colorectal polyp, flu, human, gastric cancer, gastric dysplasia, inflammatory bowel diseases, intestinal metaplasia, liver cancer, liver cirrhosis, other infectious diseases, pancreatic cancer, pancreatitis, chronic, peptic ulcer, tuberculosis